(AEIS) Advanced Energy Industries - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0079731008
Stock: Power Supplies, Measurement, Control, Plasma
Total Rating 80
Risk 90
Buy Signal 0.73
| Risk 5d forecast | |
|---|---|
| Volatility | 59.9% |
| Relative Tail Risk | -6.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.25 |
| Alpha | 150.05 |
| Character TTM | |
|---|---|
| Beta | 2.048 |
| Beta Downside | 1.954 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.87% |
| CAGR/Max DD | 1.22 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 80.6788
Description: AEIS Advanced Energy Industries March 05, 2026
Advanced Energy Industries, Inc. (AEIS) provides precision power conversion, measurement, and control solutions globally. The company operates within the semiconductor equipment and materials sector, a cyclical industry driven by technological advancements and capital expenditure from chip manufacturers.
AEISs product portfolio includes plasma power products for semiconductor and thin film processes, as well as high and low voltage power products for diverse applications like industrial production, medical equipment, and data centers. This diversified application base helps mitigate risks associated with reliance on a single industry.
The company also offers sensing, controls, and instrumentation products for power and temperature measurement. Additionally, AEIS provides aftermarket services including calibration, upgrades, and repairs, contributing to recurring revenue streams.
AEIS utilizes a direct sales force, indirect channels, and distributors for product sales and offers warranty and non-warranty repair services. To understand the companys market position and financial health, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- Semiconductor capital expenditure drives plasma power product demand
- Data center growth fuels high voltage power product sales
- Industrial production spending impacts low voltage power solutions
- Global supply chain disruptions increase manufacturing costs
- Competition from Asian manufacturers pressures pricing
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 148.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.68 > 1.0 |
| NWC/Revenue: 32.39% < 20% (prev 72.54%; Δ -40.15% < -1%) |
| CFO/TA 0.09 > 3% & CFO 233.3m > Net Income 148.4m |
| Net Debt (-112.2m) to EBITDA (229.3m): -0.49 < 3 |
| Current Ratio: 1.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (40.2m) vs 12m ago 5.79% < -2% |
| Gross Margin: 38.18% > 18% (prev 0.36%; Δ 3782 % > 0.5%) |
| Asset Turnover: 74.83% > 50% (prev 65.52%; Δ 9.31% > 0%) |
| Interest Coverage Ratio: 7.79 > 6 (EBITDA TTM 229.3m / Interest Expense TTM 15.2m) |
Altman Z'' 4.28
| A: 0.23 (Total Current Assets 1.57b - Total Current Liabilities 991.2m) / Total Assets 2.55b |
| B: 0.44 (Retained Earnings 1.13b / Total Assets 2.55b) |
| C: 0.05 (EBIT TTM 118.4m / Avg Total Assets 2.40b) |
| D: 0.96 (Book Value of Equity 1.13b / Total Liabilities 1.18b) |
| Altman-Z'' Score: 4.28 = AA |
Beneish M -3.01
| DSRI: 1.01 (Receivables 325.2m/265.3m, Revenue 1.80b/1.48b) |
| GMI: 0.94 (GM 38.18% / 35.72%) |
| AQI: 0.90 (AQ_t 0.24 / AQ_t-1 0.26) |
| SGI: 1.21 (Revenue 1.80b / 1.48b) |
| TATA: -0.03 (NI 148.4m - CFO 233.3m) / TA 2.55b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of AEIS shares?
As of March 11, 2026, the stock is trading at USD 311.39 with a total of 628,586 shares traded.
Over the past week, the price has changed by -3.44%, over one month by +11.63%, over three months by +40.64% and over the past year by +195.90%.
Over the past week, the price has changed by -3.44%, over one month by +11.63%, over three months by +40.64% and over the past year by +195.90%.
Is AEIS a buy, sell or hold?
Advanced Energy Industries has received a consensus analysts rating of 4.18.
Therefore, it is recommended to buy AEIS.
- StrongBuy: 6
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AEIS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 331.1 | 6.3% |
| Analysts Target Price | 331.1 | 6.3% |
AEIS Fundamental Data Overview March 07, 2026
P/E Trailing = 80.6788
P/E Forward = 49.7512
P/S = 6.5357
P/B = 9.1566
P/EG = 2.7718
Revenue TTM = 1.80b USD
EBIT TTM = 118.4m USD
EBITDA TTM = 229.3m USD
Long Term Debt = 566.8m USD (from longTermDebt, two quarters ago)
Short Term Debt = 583.3m USD (from shortTermDebt, last quarter)
Debt = 679.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -112.2m USD (from netDebt column, last quarter)
Enterprise Value = 11.64b USD (11.76b + Debt 679.0m - CCE 791.2m)
Interest Coverage Ratio = 7.79 (Ebit TTM 118.4m / Interest Expense TTM 15.2m)
EV/FCF = 92.49x (Enterprise Value 11.64b / FCF TTM 125.9m)
FCF Yield = 1.08% (FCF TTM 125.9m / Enterprise Value 11.64b)
FCF Margin = 7.00% (FCF TTM 125.9m / Revenue TTM 1.80b)
Net Margin = 8.25% (Net Income TTM 148.4m / Revenue TTM 1.80b)
Gross Margin = 38.18% ((Revenue TTM 1.80b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 39.44% (prev 38.83%)
Tobins Q-Ratio = 4.57 (Enterprise Value 11.64b / Total Assets 2.55b)
Interest Expense / Debt = 0.60% (Interest Expense 4.10m / Debt 679.0m)
Taxrate = 8.22% (4.70m / 57.2m)
NOPAT = 108.7m (EBIT 118.4m * (1 - 8.22%))
Current Ratio = 1.59 (Total Current Assets 1.57b / Total Current Liabilities 991.2m)
Debt / Equity = 0.50 (Debt 679.0m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = -0.49 (Net Debt -112.2m / EBITDA 229.3m)
Debt / FCF = -0.89 (Net Debt -112.2m / FCF TTM 125.9m)
Total Stockholder Equity = 1.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.17% (Net Income 148.4m / Total Assets 2.55b)
RoE = 11.51% (Net Income TTM 148.4m / Total Stockholder Equity 1.29b)
RoCE = 6.38% (EBIT 118.4m / Capital Employed (Equity 1.29b + L.T.Debt 566.8m))
RoIC = 5.86% (NOPAT 108.7m / Invested Capital 1.86b)
WACC = 12.76% (E(11.76b)/V(12.44b) * Re(13.46%) + D(679.0m)/V(12.44b) * Rd(0.60%) * (1-Tc(0.08)))
Discount Rate = 13.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.42%
[DCF] Terminal Value 65.08% ; FCFF base≈105.1m ; Y1≈118.3m ; Y5≈158.6m
[DCF] Fair Price = 39.95 (EV 1.40b - Net Debt -112.2m = Equity 1.51b / Shares 37.8m; r=12.76% [WACC]; 5y FCF grow 14.56% → 2.90% )
EPS Correlation: 0.39 | EPS CAGR: 12.68% | SUE: 1.37 | # QB: 5
Revenue Correlation: -5.58 | Revenue CAGR: 5.71% | SUE: 1.59 | # QB: 5
EPS next Quarter (2026-06-30): EPS=2.00 | Chg7d=+0.000 | Chg30d=+0.220 | Revisions Net=+8 | Analysts=10
EPS current Year (2026-12-31): EPS=8.60 | Chg7d=+0.000 | Chg30d=+0.768 | Revisions Net=+10 | Growth EPS=+34.1% | Growth Revenue=+19.4%
EPS next Year (2027-12-31): EPS=10.51 | Chg7d=+0.000 | Chg30d=+1.439 | Revisions Net=+5 | Growth EPS=+22.3% | Growth Revenue=+13.2%
[Analyst] Revisions Ratio: +1.00 (8 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.2% (Discount Rate 13.5% - Earnings Yield 1.2%)
[Growth] Growth Spread = +5.8% (Analyst 18.0% - Implied 12.2%)
P/E Forward = 49.7512
P/S = 6.5357
P/B = 9.1566
P/EG = 2.7718
Revenue TTM = 1.80b USD
EBIT TTM = 118.4m USD
EBITDA TTM = 229.3m USD
Long Term Debt = 566.8m USD (from longTermDebt, two quarters ago)
Short Term Debt = 583.3m USD (from shortTermDebt, last quarter)
Debt = 679.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -112.2m USD (from netDebt column, last quarter)
Enterprise Value = 11.64b USD (11.76b + Debt 679.0m - CCE 791.2m)
Interest Coverage Ratio = 7.79 (Ebit TTM 118.4m / Interest Expense TTM 15.2m)
EV/FCF = 92.49x (Enterprise Value 11.64b / FCF TTM 125.9m)
FCF Yield = 1.08% (FCF TTM 125.9m / Enterprise Value 11.64b)
FCF Margin = 7.00% (FCF TTM 125.9m / Revenue TTM 1.80b)
Net Margin = 8.25% (Net Income TTM 148.4m / Revenue TTM 1.80b)
Gross Margin = 38.18% ((Revenue TTM 1.80b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 39.44% (prev 38.83%)
Tobins Q-Ratio = 4.57 (Enterprise Value 11.64b / Total Assets 2.55b)
Interest Expense / Debt = 0.60% (Interest Expense 4.10m / Debt 679.0m)
Taxrate = 8.22% (4.70m / 57.2m)
NOPAT = 108.7m (EBIT 118.4m * (1 - 8.22%))
Current Ratio = 1.59 (Total Current Assets 1.57b / Total Current Liabilities 991.2m)
Debt / Equity = 0.50 (Debt 679.0m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = -0.49 (Net Debt -112.2m / EBITDA 229.3m)
Debt / FCF = -0.89 (Net Debt -112.2m / FCF TTM 125.9m)
Total Stockholder Equity = 1.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.17% (Net Income 148.4m / Total Assets 2.55b)
RoE = 11.51% (Net Income TTM 148.4m / Total Stockholder Equity 1.29b)
RoCE = 6.38% (EBIT 118.4m / Capital Employed (Equity 1.29b + L.T.Debt 566.8m))
RoIC = 5.86% (NOPAT 108.7m / Invested Capital 1.86b)
WACC = 12.76% (E(11.76b)/V(12.44b) * Re(13.46%) + D(679.0m)/V(12.44b) * Rd(0.60%) * (1-Tc(0.08)))
Discount Rate = 13.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.42%
[DCF] Terminal Value 65.08% ; FCFF base≈105.1m ; Y1≈118.3m ; Y5≈158.6m
[DCF] Fair Price = 39.95 (EV 1.40b - Net Debt -112.2m = Equity 1.51b / Shares 37.8m; r=12.76% [WACC]; 5y FCF grow 14.56% → 2.90% )
EPS Correlation: 0.39 | EPS CAGR: 12.68% | SUE: 1.37 | # QB: 5
Revenue Correlation: -5.58 | Revenue CAGR: 5.71% | SUE: 1.59 | # QB: 5
EPS next Quarter (2026-06-30): EPS=2.00 | Chg7d=+0.000 | Chg30d=+0.220 | Revisions Net=+8 | Analysts=10
EPS current Year (2026-12-31): EPS=8.60 | Chg7d=+0.000 | Chg30d=+0.768 | Revisions Net=+10 | Growth EPS=+34.1% | Growth Revenue=+19.4%
EPS next Year (2027-12-31): EPS=10.51 | Chg7d=+0.000 | Chg30d=+1.439 | Revisions Net=+5 | Growth EPS=+22.3% | Growth Revenue=+13.2%
[Analyst] Revisions Ratio: +1.00 (8 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.2% (Discount Rate 13.5% - Earnings Yield 1.2%)
[Growth] Growth Spread = +5.8% (Analyst 18.0% - Implied 12.2%)